Related references
Note: Only part of the references are listed.Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats
Osama Ahmed et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Anticolitic activity of prodigiosin loaded with selenium nanoparticles on acetic acid-induced colitis in rats
Rami B. Kassab et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)
Novel drug delivery systems for inflammatory bowel disease
Farah Yasmin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2022)
Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Zhaobei Cai et al.
FRONTIERS IN MEDICINE (2021)
Drug Targeting of Inflammatory Bowel Diseases by Biomolecules
Joana Costa Antunes et al.
NANOMATERIALS (2021)
Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis
Meisi Lin et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract-Influence of Physiological, Pathophysiological and Pharmaceutical Factors
Susan Hua
FRONTIERS IN PHARMACOLOGY (2020)
Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model
Milad Reda Qelliny et al.
AAPS PHARMSCITECH (2019)
Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease
Gurpreet Kaur Sinhmar et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa
Seyed Yaser Vafaei et al.
CARBOHYDRATE POLYMERS (2016)
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
E. G. Quetglas et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis
Guray Can et al.
JOURNAL OF CROHNS & COLITIS (2015)
Oral budesonide for induction of remission in ulcerative colitis
Mary E. Sherlock et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
H. Ali et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Protective Effect of Hydroalcoholic Olive Leaf Extract on Experimental Model of Colitis in Rat: Involvement of Nitrergic and Opioidergic Systems
Nahid Fakhraei et al.
PHYTOTHERAPY RESEARCH (2014)
Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
Marisa Iborra et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2014)
Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission
Laura Rosenberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Risks of Inflammatory Bowel Disease Treatment with Glucocorticosteroids and Aminosalicylates
Ivanka Curkovic et al.
DIGESTIVE DISEASES (2013)
Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis
Ana Beloqui et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa-A first in vivo study in human patients
Carsten Schmidt et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Eva-Maria Collnot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications
Carole E. Schante et al.
CARBOHYDRATE POLYMERS (2011)
N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in rats
C. Mura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis
Jaleh Varshosaz et al.
JOURNAL OF DRUG TARGETING (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles
K. Mladenovska et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies
Daniel C. Baumgart et al.
LANCET (2007)
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
RB Sartor
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)
Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions
Bernadette Begue et al.
GASTROENTEROLOGY (2006)
Budesonicle in the treatment of inflammatory bowel disease: The first year of experience in clinical practice
A Chopra et al.
INFLAMMATORY BOWEL DISEASES (2006)
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes
TT Jubeh et al.
PHARMACEUTICAL RESEARCH (2004)
A pharmacoscintigraphic evaluation of oral budesonide given as controlled-release (Entocort) capsules
S Edsbäcker et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa
A Lamprecht et al.
PHARMACEUTICAL RESEARCH (2001)
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs
SG Nugent et al.
GUT (2001)
Lectin-mediated drug delivery: The second generation of bioadhesives
CM Lehr
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
